Published in Eur J Med Chem on October 31, 2009
68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer. J Med Chem (2010) 1.51
Medical applications and toxicities of gallium compounds. Int J Environ Res Public Health (2010) 1.15
Gallium-containing anticancer compounds. Future Med Chem (2012) 0.86
Iron-targeting antitumor activity of gallium compounds and novel insights into triapine(®)-metal complexes. Antioxid Redox Signal (2012) 0.84
Cytotoxicity, apoptosis and study of the DNA-binding properties of bi- and tetranuclear gallium(III) complexes with heterocyclic thiolato ligands. Invest New Drugs (2010) 0.77
Gallium-Loaded Dissolvable Microfilm Constructs that Provide Sustained Release of Ga(3+) for Management of Biofilms. Adv Healthc Mater (2015) 0.76
Biological study of the effect of water soluble [N-(2-hydroxybenzyl)-L-aspartato] gallium complexes on breast carcinoma and fibrosarcoma cells. J Biol Inorg Chem (2016) 0.75
Interesting coordination abilities of antiulcer drug famotidine and antimicrobial activity of drug and its cobalt(III) complex. J Inorg Biochem (2006) 1.39
Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties. J Inorg Biochem (2012) 1.10
Oligodentate P,N ligands: N,N,N',N'-tetrakis(diphenylphosphanyl)-1,3-diaminobenzene complexes of rhodium, nickel and palladium. Dalton Trans (2005) 1.08
Carbaboranes as pharmacophores: properties, synthesis, and application strategies. Chem Rev (2011) 0.99
Synthesis, characterization, and crystal structures of novel intramolecularly base-stabilized borane derivatives with six- and seven-membered chelate rings. Inorg Chem (2004) 0.98
Hexaaqua-magnesium(II) bis-(d-camphor-10-sulfonate). Acta Crystallogr Sect E Struct Rep Online (2008) 0.96
In vitro anticancer studies of alpha- and beta-D-glucopyranose betulin anomers. Chem Biol Interact (2010) 0.95
Synthesis and in vitro antitumoral activity of novel O,O'-di-2-alkyl-(S,S)-ethylenediamine-N,N'-di-2-propanoate ligands and corresponding platinum(II/IV) complexes. J Inorg Biochem (2007) 0.91
Synthesis, structure and luminescence properties of a cadmium(II)-based coordination polymer with (S)-4,4'-bis(4-carboxyphenyl)-2,2'-bis(diphenylphosphinoyl)-1,1'-binaphthyl as chiral linker. Dalton Trans (2014) 0.87
Lupane triterpenoids--betulin and betulinic acid derivatives induce apoptosis in tumor cells. Invest New Drugs (2009) 0.87
Cytotoxic studies of substituted titanocene and ansa-titanocene anticancer drugs. J Inorg Biochem (2008) 0.87
Increased betulinic acid induced cytotoxicity and radiosensitivity in glioma cells under hypoxic conditions. Radiat Oncol (2011) 0.85
Reactions of 1-alkyl-1,2-diphospholes with 1,3-dipoles: diphenyldiazomethane and nitrones. Org Biomol Chem (2012) 0.85
Carbaboranes as pharmacophores: similarities and differences between aspirin and asborin. Eur J Med Chem (2011) 0.84
Asborin: the carbaborane analogue of aspirin. ChemMedChem (2009) 0.84
Small structural changes of pentacyclic lupane type triterpenoid derivatives lead to significant differences in their anticancer properties. Eur J Med Chem (2010) 0.84
Preparation of betulinic acid derivatives by chemical and biotransformation methods and determination of cytotoxicity against selected cancer cell lines. Eur J Med Chem (2013) 0.84
Synthesis and evaluation of carbaborane derivatives of indomethacin as cyclooxygenase inhibitors. Bioorg Med Chem (2011) 0.82
Brassicaceae contain nortropane alkaloids. Phytochemistry (2006) 0.82
Conjugates of cisplatin and cyclooxygenase inhibitors as potent antitumor agents overcoming cisplatin resistance. ChemMedChem (2014) 0.82
Platinum(II) and palladium(II) complexes of chiral P-Cl functionalized bis-phosphino ortho-carbaboranes. Inorg Chem (2009) 0.81
Synthesis and in vitro anticancer activity of octahedral platinum(IV) complexes with cyclohexyl-functionalized ethylenediamine-N,N'-diacetate-type ligands. ChemMedChem (2010) 0.81
Ortho-carbaborane derivatives of indomethacin as cyclooxygenase (COX)-2 selective inhibitors. Bioorg Med Chem (2012) 0.81
Ruthenium(II) polypyridyl complexes as carriers for DNA delivery. Chem Commun (Camb) (2011) 0.80
Betulinic acid regulates generation of neuroinflammatory mediators responsible for tissue destruction in multiple sclerosis in vitro. Acta Pharmacol Sin (2013) 0.80
Anti-cancer applications of titanocene-functionalised nanostructured systems: an insight into cell death mechanisms. Chemistry (2014) 0.80
A facile sol-gel synthesis of impurity-free nanocrystalline titania. Phys Chem Chem Phys (2014) 0.80
Antiproliferative effect of novel platinum(II) and palladium(II) complexes on hepatic tumor stem cells in vitro. Eur J Med Chem (2011) 0.80
Asborin inhibits Aldo/Keto reductase 1A1. ChemMedChem (2011) 0.80
Conjugation of cisplatin analogues and cyclooxygenase inhibitors to overcome cisplatin resistance. ChemMedChem (2014) 0.80
2-Carbaborane-3-phenyl-1H-indoles--synthesis via McMurry reaction and cyclooxygenase (COX) inhibition activity. ChemMedChem (2013) 0.79
Carbamate derivatives of betulinic acid and betulin with selective cytotoxic activity. Bioorg Med Chem Lett (2010) 0.79
Synthesis and anticancer activity of novel betulinic acid and betulin derivatives. Arch Pharm (Weinheim) (2010) 0.78
Study of the cytotoxic activity of di and triphenyltin(IV) carboxylate complexes. J Inorg Biochem (2008) 0.78
Synthesis and biological evaluation of antitumour-active betulin derivatives. Bioorg Med Chem (2009) 0.78
Reaction of a heterotopic P,SAs ligand with group 10 metal(II) complexes: As-S bond cleavage and the formation of two unusual trinuclear structural isomers for Pd and Pt. Dalton Trans (2012) 0.78
A new generation of anticancer drugs: mesoporous materials modified with titanocene complexes. Chemistry (2009) 0.77
Cytotoxicity, apoptosis and study of the DNA-binding properties of bi- and tetranuclear gallium(III) complexes with heterocyclic thiolato ligands. Invest New Drugs (2010) 0.77
Heteropolytopic phosphanylarylthiolato ligands: formation of cis isomers of nickel(II), palladium(III) and platinum(III) complexes with 1-P(Biph)-2-SHC6H4 (Biph = 1,1'-biphenyl-2,2'-diyl). Dalton Trans (2012) 0.77
Incorporation of ortho-carbaboranyl-Nε-modified L-lysine into neuropeptide Y receptor Y1- and Y2-selective analogues. J Med Chem (2011) 0.77
Platinum(II/IV) complexes containing ethylenediamine-N,N'-di-2/3-propionate ester ligands induced caspase-dependent apoptosis in cisplatin-resistant colon cancer cells. Metallomics (2012) 0.77
Synthesis and biological applications of ionic triphenyltin(IV) chloride carboxylate complexes with exceptionally high cytotoxicity. Metallomics (2010) 0.77
Synthesis and biological evaluation of antitumor-active gamma-butyrolactone substituted betulin derivatives. Bioorg Med Chem (2010) 0.77
Synthesis, characterization, in vitro antitumoral investigations and interaction with plasmid pBR322 DNA of R2eddp-platinum(IV) complexes (R = Et, n-Pr). Dalton Trans (2009) 0.77
Heteropolytopic arsanylarylthiolato ligands: cis-trans isomerism of nickel(II), palladium(II), and platinum(II) complexes of 1-AsPh2-2-SHC6H4. Inorg Chem (2012) 0.77
Aminoalkylferrocenyldichlorophosphanes: facile synthesis of versatile chiral starting materials. Dalton Trans (2007) 0.76
Cationic arene ruthenium(II) complexes with chelating P-functionalized alkyl phenyl sulfide and sulfoxide ligands as potent anticancer agents. Dalton Trans (2013) 0.76
Anticancer Activity of Organogallium(III) Complexes in Colon Cancer Cells. Anticancer Agents Med Chem (2016) 0.76
Lipophilic Pt(II) complexes with selective efficacy against cisplatin-resistant testicular cancer cells. J Inorg Biochem (2011) 0.76
Receptor-mediated uptake of boron-rich neuropeptide y analogues for boron neutron capture therapy. ChemMedChem (2014) 0.76
Study of the anticancer properties of tin(IV) carboxylate complexes on a panel of human tumor cell lines. ChemMedChem (2011) 0.76
Improvement of cytotoxicity of titanocene-functionalized mesoporous materials by the increase of the titanium content. Dalton Trans (2010) 0.76
Self-association of ruthenium(II) polypyridyl complexes and their interactions with calf thymus DNA. Inorg Chem (2010) 0.76
The reactivity of gallium-(I), -(II) and -(III) heterocycles towards Group 15 substrates: attempts to prepare gallium-terminal pnictinidene complexes. Dalton Trans (2005) 0.76
Organogallium(III) complexes as apoptosis promoting anticancer agents for head and neck squamous cell carcinoma (HNSCC) cell lines. J Inorg Biochem (2010) 0.76
Novel trans-dichloridoplatinum(II) complexes with 3- and 4-acetylpyridine: Synthesis, characterization, DFT calculations and cytotoxicity. Eur J Med Chem (2008) 0.76
Redox control of a dendritic ferrocenyl-based homogeneous catalyst. Angew Chem Int Ed Engl (2014) 0.75
N,N'-Bis[2-(methoxycarbonyl)ethyl]ethane-1,2-diammonium dichloride. Acta Crystallogr Sect E Struct Rep Online (2008) 0.75
2,2'-{1,1'-[2,2'-Oxalylbis(hydrazin-2-yl-1-yl-idene)]diethyl-idyne}dipyridinium bis-(perchlorate) dihydrate. Acta Crystallogr Sect E Struct Rep Online (2010) 0.75
Bis[1,2-bis-(dimethyl-phosphino)ethane-κP,P']rhodium(I) dichlorido[(1,2,5,6-η)-1,5-cyclo-octa-diene]rhodium(I). Acta Crystallogr Sect E Struct Rep Online (2008) 0.75
Study of the cytotoxicity and particle action in human cancer cells of titanocene-functionalized materials with potential application against tumors. J Inorg Biochem (2011) 0.75
(S,S)-N,N'-Bis(1-carb-oxy-2-methyl-prop-yl)ethyl-enediammonium dihalide cyclo-penta-nol tetra-solvate (halide = bromide/chloride ≃ 1:12). Acta Crystallogr Sect E Struct Rep Online (2009) 0.75
Monoterpenes as drug shuttles: cytotoxic (6-aminomethylnicotinate)dichloridoplatinum(II) complexes with potential to overcome cisplatin resistance. J Med Chem (2007) 0.75
[Disulfanediylbis(ferrocenyl-thio-phosphinato)-κ(2)O,O]titanocene tetra-hydro-furan tris-olvate. Acta Crystallogr Sect E Struct Rep Online (2012) 0.75
Selective formation of silver(i) bis-phospholane macrocycles and further evidence that gold(i) is smaller than silver(i). Dalton Trans (2016) 0.75
P-chiral 1-phosphanorbornenes: from asymmetric phospha-Diels-Alder reactions towards ligand design and functionalisation. Dalton Trans (2015) 0.75
Tungsten phosphanylarylthiolato complexes [W{PhP(2-SC6H4)2-kappa3S,S',P} 2] and [W{P(2-SC6H4)3-kappa4S,S',S",P}2]: synthesis, structures and redox chemistry. Dalton Trans (2008) 0.75
Tetraaquabis(D-camphor-10-sulfonato)calcium(II). Acta Crystallogr C (2009) 0.75
When arsine makes the difference: chelating phosphino and bridging arsinoarylthiolato gallium complexes. Inorg Chem (2008) 0.75
Coordination chemistry of the cyclo-(P(5)tBu(4))(-) ion: monomeric and oligomeric copper(I), silver(I) and gold(I) complexes. Chemistry (2008) 0.75
Palladium(II) complexes with R2edda-derived ligands. Part II. Synthesis, characterization and in vitro antitumoral studies of R2eddip esters and palladium(II) complexes. Eur J Med Chem (2009) 0.75
P--P bond cleavage of tetraphenyltetraphosphane-1,4-diide facilitated by nickel(0). Chemistry (2008) 0.75
Cytotoxicity of some platinum(IV) complexes with ethylenediamine-N,N'-di-3-propionato ligand. J Inorg Biochem (2004) 0.75
Platinum(II) tetramesityltetraphosphane-1,4-diides. Dalton Trans (2009) 0.75
Ruthenium complexes with dendritic ferrocenyl phosphanes: synthesis, characterization, and application in the catalytic redox isomerization of allylic alcohols. Chemistry (2015) 0.75
Synthesis and magnetic properties of manganese carbonyl complexes with different coordination modes of 3,4,5-triaryl-1,2-diphospholide ligands. Dalton Trans (2015) 0.75
Synthesis and unique reversible splitting of 14-membered cyclic aminomethylphosphines on to 7-membered heterocycles. Dalton Trans (2015) 0.75
The CellScan technology for in vitro studies on novel platinum complexes with organoarsenic ligands. Dalton Trans (2008) 0.75
Access to carbaboranyl glycophosphonates--an odyssey. Inorg Chem (2009) 0.75
Hydrophosphination reactions with transition metal ferrocenylphosphine complexes. Dalton Trans (2015) 0.75
Evaluation of functionalized mesoporous silica SBA-15 as a carrier system for Ph3Sn(CH2)3OH against the A2780 ovarian carcinoma cell line. Dalton Trans (2016) 0.75